Type 2 Diabetes Trial, Recruiting NCT07032844 Sponsor: University of Alabama at Birmingham Condition: Type 2 Diabetes
Back to Type 2 Diabetes

Type 2 Diabetes Trial, Recruiting

NCT07032844
Recruiting Not Applicable

voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice

Who may and may not be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who may be able to join

  • People who have a physical disability
  • People who have been diagnosed with Type 2 Diabetes
  • People whose blood sugar control measure (called HbA1c) was 7% or higher within the past 3 months before screening
  • People who have been diagnosed with at least one additional long-term health condition from this list: high blood pressure, heart failure, coronary artery disease, high cholesterol, stroke, arthritis, asthma, cancer, chronic kidney disease (stages 1–4), COPD, osteoporosis, multiple sclerosis, or Parkinson's disease

Who may not be able to join

Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.

  • People who have an intellectual, learning, or developmental disability
  • People who do not speak English
  • People who are currently pregnant
  • People whose vision loss is significant enough to prevent use of a phone or tablet for the study activities
  • People who have received remote patient monitoring or digital health coaching for Type 2 Diabetes management within the 30 days before enrolling
  • People who have end-stage kidney disease and are currently on dialysis
  • People who do not have a physical disability
  • People who appear unwilling or unable to take part in the trial (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 31 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Tapan Mehta, PhD, University of Alabama at Birmingham

Phone: 205-201-1507

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
15 September 2026
Est. completion
1 December 2027

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Change in Hemoglobin A1c

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 31 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov